Does the media prefer Z or ASTH?

In the previous week, Zillow Group had 9 more articles in the media than Astrana Health. MarketBeat recorded 12 mentions for Zillow Group and 3 mentions for Astrana Health. Zillow Group's average media sentiment score of 0.74 beat Astrana Health's score of 0.62 indicating that Zillow Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Zillow Group 4 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Astrana Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ASTH or HQY?

In the previous week, HealthEquity had 21 more articles in the media than Astrana Health. MarketBeat recorded 24 mentions for HealthEquity and 3 mentions for Astrana Health. Astrana Health's average media sentiment score of 0.62 beat HealthEquity's score of 0.60 indicating that Astrana Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Astrana Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive HealthEquity 7 Very Positive mention(s) 3 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation & earnings, BILI or ASTH?

Bilibili has higher revenue and earnings than Astrana Health. Bilibili is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Bilibili $4.34B 1.71 $170.67M $0.45 39.67 Astrana Health $3.18B 0.64 $22.49M $0.61 60.16

Does the media prefer BILI or ASTH?

In the previous week, Bilibili and Bilibili both had 3 articles in the media. Astrana Health's average media sentiment score of 0.62 beat Bilibili's score of 0.57 indicating that Astrana Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Bilibili 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Astrana Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate ASTH or QMMM?

Astrana Health presently has a consensus target price of $45.00, suggesting a potential upside of 22.62%. Given Astrana Health's stronger consensus rating and higher probable upside, analysts plainly believe Astrana Health is more favorable than QMMM. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Astrana Health 0 Sell rating(s) 2 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.78 QMMM 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better earnings & valuation, ASTH or QMMM?

Astrana Health has higher revenue and earnings than QMMM. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Astrana Health $3.18B 0.64 $22.49M $0.61 60.16 QMMM $2.70M 2,529.95 -$1.58M N/A N/A

Does the media favor FIGR or ASTH?

In the previous week, Figure Technology Solutions had 7 more articles in the media than Astrana Health. MarketBeat recorded 10 mentions for Figure Technology Solutions and 3 mentions for Astrana Health. Figure Technology Solutions' average media sentiment score of 1.26 beat Astrana Health's score of 0.62 indicating that Figure Technology Solutions is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Figure Technology Solutions 4 Very Positive mention(s) 3 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Astrana Health 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Astrana Health (ASTH) Competitors

$36.70 -0.21 (-0.57%)

Closing price 04:00 PM Eastern

Extended Trading

$36.71 +0.01 (+0.03%)

As of 04:10 PM Eastern

Compare

ASTH vs. Z, HQY, BILI, QMMM, and FIGR

Should you buy Astrana Health stock or one of its competitors? MarketBeat compares Astrana Health with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Astrana Health include Zillow Group (Z), HealthEquity (HQY), Bilibili (BILI), QMMM (QMMM), and Figure Technology Solutions (FIGR). These companies are all part of the "business services" industry.

How does Astrana Health compare to Zillow Group?

Zillow Group (NASDAQ:Z) and Astrana Health (NASDAQ:ASTH) are both mid-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, profitability, earnings, dividends and risk.

Zillow Group has higher earnings, but lower revenue than Astrana Health. Astrana Health is trading at a lower price-to-earnings ratio than Zillow Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zillow Group	$2.58B	3.15	$23M	$0.25	142.04
Astrana Health	$3.18B	0.64	$22.49M	$0.61	60.16

Zillow Group has a net margin of 2.27% compared to Astrana Health's net margin of 0.86%. Astrana Health's return on equity of 9.22% beat Zillow Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zillow Group	2.27%	1.41%	1.22%
Astrana Health	0.86%	9.22%	3.54%

71.0% of Zillow Group shares are held by institutional investors. Comparatively, 52.8% of Astrana Health shares are held by institutional investors. 25.0% of Zillow Group shares are held by company insiders. Comparatively, 20.3% of Astrana Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Zillow Group had 9 more articles in the media than Astrana Health. MarketBeat recorded 12 mentions for Zillow Group and 3 mentions for Astrana Health. Zillow Group's average media sentiment score of 0.74 beat Astrana Health's score of 0.62 indicating that Zillow Group is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Zillow Group	4 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Astrana Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Zillow Group has a beta of 1.97, meaning that its stock price is 97% more volatile than the broader market. Comparatively, Astrana Health has a beta of 1, meaning that its stock price has a similar volatility profile to the broader market.

Zillow Group currently has a consensus price target of $77.00, suggesting a potential upside of 116.84%. Astrana Health has a consensus price target of $45.00, suggesting a potential upside of 22.62%. Given Zillow Group's higher probable upside, analysts clearly believe Zillow Group is more favorable than Astrana Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zillow Group	1 Sell rating(s)	6 Hold rating(s)	4 Buy rating(s)	3 Strong Buy rating(s)	2.64
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78

Summary

Zillow Group beats Astrana Health on 11 of the 17 factors compared between the two stocks.

How does Astrana Health compare to HealthEquity?

Astrana Health (NASDAQ:ASTH) and HealthEquity (NASDAQ:HQY) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, profitability, risk, dividends, institutional ownership, earnings, valuation and analyst recommendations.

52.8% of Astrana Health shares are held by institutional investors. Comparatively, 99.6% of HealthEquity shares are held by institutional investors. 20.3% of Astrana Health shares are held by insiders. Comparatively, 1.6% of HealthEquity shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

HealthEquity has a net margin of 17.25% compared to Astrana Health's net margin of 0.86%. HealthEquity's return on equity of 14.75% beat Astrana Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Astrana Health	0.86%	9.22%	3.54%
HealthEquity	17.25%	14.75%	9.22%

HealthEquity has lower revenue, but higher earnings than Astrana Health. HealthEquity is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$3.18B	0.64	$22.49M	$0.61	60.16
HealthEquity	$1.31B	5.42	$215.20M	$2.67	31.91

Astrana Health presently has a consensus price target of $45.00, suggesting a potential upside of 22.62%. HealthEquity has a consensus price target of $111.53, suggesting a potential upside of 30.89%. Given HealthEquity's stronger consensus rating and higher probable upside, analysts clearly believe HealthEquity is more favorable than Astrana Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78
HealthEquity	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	2.87

Astrana Health has a beta of 1, suggesting that its share price has a similar volatility profile to the broader market.Comparatively, HealthEquity has a beta of 0.21, suggesting that its share price is 79% less volatile than the broader market.

In the previous week, HealthEquity had 21 more articles in the media than Astrana Health. MarketBeat recorded 24 mentions for HealthEquity and 3 mentions for Astrana Health. Astrana Health's average media sentiment score of 0.62 beat HealthEquity's score of 0.60 indicating that Astrana Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Astrana Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
HealthEquity	7 Very Positive mention(s)	3 Positive mention(s)	6 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

HealthEquity beats Astrana Health on 12 of the 17 factors compared between the two stocks.

How does Astrana Health compare to Bilibili?

Bilibili (NASDAQ:BILI) and Astrana Health (NASDAQ:ASTH) are both mid-cap business services companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, valuation, institutional ownership and dividends.

Bilibili has a net margin of 4.58% compared to Astrana Health's net margin of 0.86%. Bilibili's return on equity of 10.81% beat Astrana Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Bilibili	4.58%	10.81%	4.04%
Astrana Health	0.86%	9.22%	3.54%

Bilibili has higher revenue and earnings than Astrana Health. Bilibili is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bilibili	$4.34B	1.71	$170.67M	$0.45	39.67
Astrana Health	$3.18B	0.64	$22.49M	$0.61	60.16

16.1% of Bilibili shares are held by institutional investors. Comparatively, 52.8% of Astrana Health shares are held by institutional investors. 22.2% of Bilibili shares are held by company insiders. Comparatively, 20.3% of Astrana Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Bilibili and Bilibili both had 3 articles in the media. Astrana Health's average media sentiment score of 0.62 beat Bilibili's score of 0.57 indicating that Astrana Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Bilibili	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Astrana Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Bilibili has a beta of 0.71, indicating that its stock price is 29% less volatile than the broader market. Comparatively, Astrana Health has a beta of 1, indicating that its stock price has a similar volatility profile to the broader market.

Bilibili currently has a consensus price target of $30.78, indicating a potential upside of 72.42%. Astrana Health has a consensus price target of $45.00, indicating a potential upside of 22.62%. Given Bilibili's stronger consensus rating and higher possible upside, equities research analysts plainly believe Bilibili is more favorable than Astrana Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bilibili	0 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.90
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78

Summary

Bilibili beats Astrana Health on 11 of the 15 factors compared between the two stocks.

How does Astrana Health compare to QMMM?

Astrana Health (NASDAQ:ASTH) and QMMM (NASDAQ:QMMM) are both mid-cap business services companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk and profitability.

Astrana Health has a beta of 1, indicating that its share price has a similar volatility profile to the broader market.Comparatively, QMMM has a beta of 13.97, indicating that its share price is 1,297% more volatile than the broader market.

52.8% of Astrana Health shares are held by institutional investors. 20.3% of Astrana Health shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Astrana Health has higher revenue and earnings than QMMM.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Astrana Health	$3.18B	0.64	$22.49M	$0.61	60.16
QMMM	$2.70M	2,529.95	-$1.58M	N/A	N/A

In the previous week, Astrana Health had 2 more articles in the media than QMMM. MarketBeat recorded 3 mentions for Astrana Health and 1 mentions for QMMM. QMMM's average media sentiment score of 1.89 beat Astrana Health's score of 0.62 indicating that QMMM is being referred to more favorably in the news media.

Company	Overall Sentiment
Astrana Health	Positive
QMMM	Very Positive

Astrana Health has a net margin of 0.86% compared to QMMM's net margin of 0.00%. Astrana Health's return on equity of 9.22% beat QMMM's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Astrana Health	0.86%	9.22%	3.54%
QMMM	N/A	N/A	N/A

Astrana Health presently has a consensus target price of $45.00, suggesting a potential upside of 22.62%. Given Astrana Health's stronger consensus rating and higher probable upside, analysts plainly believe Astrana Health is more favorable than QMMM.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78
QMMM	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Summary

Astrana Health beats QMMM on 11 of the 14 factors compared between the two stocks.

How does Astrana Health compare to Figure Technology Solutions?

Figure Technology Solutions (NASDAQ:FIGR) and Astrana Health (NASDAQ:ASTH) are both mid-cap business services companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, institutional ownership, media sentiment, risk, dividends, analyst recommendations, profitability and earnings.

In the previous week, Figure Technology Solutions had 7 more articles in the media than Astrana Health. MarketBeat recorded 10 mentions for Figure Technology Solutions and 3 mentions for Astrana Health. Figure Technology Solutions' average media sentiment score of 1.26 beat Astrana Health's score of 0.62 indicating that Figure Technology Solutions is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Figure Technology Solutions	4 Very Positive mention(s)	3 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Astrana Health	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Figure Technology Solutions presently has a consensus target price of $53.63, suggesting a potential upside of 73.10%. Astrana Health has a consensus target price of $45.00, suggesting a potential upside of 22.62%. Given Figure Technology Solutions' higher possible upside, research analysts plainly believe Figure Technology Solutions is more favorable than Astrana Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Figure Technology Solutions	2 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.64
Astrana Health	0 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.78

Astrana Health has a net margin of 0.86% compared to Figure Technology Solutions' net margin of 0.00%. Astrana Health's return on equity of 9.22% beat Figure Technology Solutions' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Figure Technology Solutions	N/A	N/A	N/A
Astrana Health	0.86%	9.22%	3.54%

52.8% of Astrana Health shares are held by institutional investors. 26.6% of Figure Technology Solutions shares are held by company insiders. Comparatively, 20.3% of Astrana Health shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Figure Technology Solutions has higher earnings, but lower revenue than Astrana Health. Figure Technology Solutions is trading at a lower price-to-earnings ratio than Astrana Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Figure Technology Solutions	$506.86M	11.16	$133.86M	$0.58	53.41
Astrana Health	$3.18B	0.64	$22.49M	$0.61	60.16

Summary

Astrana Health beats Figure Technology Solutions on 8 of the 15 factors compared between the two stocks.

Get Astrana Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ASTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ASTH vs. The Competition

Export

Metric	Astrana Health	MED Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.06B	$5.53B	$6.45B	$12.42B
Dividend Yield	N/A	1.60%	2.69%	5.29%
P/E Ratio	24.94	32.83	22.30	24.19
Price / Sales	0.64	29.48	581.44	138.36
Price / Cash	13.12	15.97	42.31	57.88
Price / Book	2.60	3.08	9.84	6.72
Net Income	$22.49M	$218.81M	$3.57B	$337.19M
7 Day Performance	-4.72%	-2.48%	-1.16%	0.48%
1 Month Performance	5.19%	-0.36%	3.85%	5.07%
1 Year Performance	45.69%	10.32%	27.40%	34.25%

Astrana Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ASTH Astrana Health	3.8073 of 5 stars	$36.70 -0.6%	$45.00 +22.6%	+50.7%	$2.06B	$3.18B	24.94	3,000	Analyst Upgrade
Z Zillow Group	4.3215 of 5 stars	$35.74 -1.7%	$77.00 +115.4%	-46.8%	$8.31B	$2.69B	142.96	5,720
HQY HealthEquity	4.3767 of 5 stars	$87.25 -1.0%	$111.79 +28.1%	-14.1%	$7.39B	$1.31B	35.47	2,814	Earnings Report Analyst Forecast Insider Trade
BILI Bilibili	4.2824 of 5 stars	$17.78 +3.2%	$30.78 +73.1%	+1.0%	$7.15B	$30.82B	39.51	8,423	Gap Down
QMMM QMMM	0.3236 of 5 stars	$119.40 +19.4%	N/A	+10,373.7%	$6.83B	$2.70M	N/A	N/A	High Trading Volume

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ASTH) was last updated on 6/3/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Astrana Health (ASTH) Competitors

ASTH vs. Z, HQY, BILI, QMMM, and FIGR

How does Astrana Health compare to Zillow Group?

Summary

How does Astrana Health compare to HealthEquity?

Summary

How does Astrana Health compare to Bilibili?

Summary

How does Astrana Health compare to QMMM?

Summary

How does Astrana Health compare to Figure Technology Solutions?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ASTH vs. The Competition

Astrana Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Astrana Health (ASTH) Competitors

ASTH vs. Z, HQY, BILI, QMMM, and FIGR

How does Astrana Health compare to Zillow Group?

Which has stronger valuation & earnings, Z or ASTH?

Is Z or ASTH more profitable?

Do institutionals and insiders hold more shares of Z or ASTH?

Does the media prefer Z or ASTH?

Which has more volatility and risk, Z or ASTH?

Do analysts rate Z or ASTH?

Summary

How does Astrana Health compare to HealthEquity?

Do institutionals & insiders have more ownership in ASTH or HQY?

Is ASTH or HQY more profitable?

Which has stronger earnings and valuation, ASTH or HQY?

Do analysts rate ASTH or HQY?

Which has more volatility & risk, ASTH or HQY?

Does the media favor ASTH or HQY?

Summary

How does Astrana Health compare to Bilibili?

Is BILI or ASTH more profitable?

Which has stronger valuation & earnings, BILI or ASTH?

Do institutionals & insiders believe in BILI or ASTH?

Does the media prefer BILI or ASTH?

Which has more risk and volatility, BILI or ASTH?

Do analysts prefer BILI or ASTH?

Summary

How does Astrana Health compare to QMMM?

Which has more risk & volatility, ASTH or QMMM?

Do institutionals and insiders believe in ASTH or QMMM?

Which has better earnings & valuation, ASTH or QMMM?

Does the media favor ASTH or QMMM?

Is ASTH or QMMM more profitable?

Do analysts rate ASTH or QMMM?

Summary

How does Astrana Health compare to Figure Technology Solutions?

Does the media favor FIGR or ASTH?

Do analysts prefer FIGR or ASTH?

Is FIGR or ASTH more profitable?

Do institutionals and insiders hold more shares of FIGR or ASTH?

Which has better earnings & valuation, FIGR or ASTH?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ASTH vs. The Competition

Astrana Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools